4//SEC Filing
Dolecek Gayle R 4
Accession 0001144204-11-029665
CIK 0001365216other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 1:05 PM ET
Size
7.8 KB
Accession
0001144204-11-029665
Insider Transaction Report
Form 4
Dolecek Gayle R
DirectorVP of Research & Development
Transactions
- Award
Employee Stock Option (Right to buy)
2011-05-02+112,500→ 112,500 totalExercise: $4.41Exp: 2021-05-02→ Class A common stock (112,500 underlying) - Award
Employee Stock Option (Right to buy)
2011-05-02+57,600→ 57,600 totalExercise: $4.41Exp: 2021-05-02→ Class A common stock (57,600 underlying)
Footnotes (2)
- [F1]Commencing on May 2, 2012, the first anniversary of the original grant date, the option vests annually with respect to 25% of the aggregate option share total.
- [F2]Performance Conditions for vesting: 40% when the Fair Market Value of a share of Common Stock determined over any 30 consecutive trading days equals or exceeds $8/sh = 45,000; 40% when the Fair Market Value of a share of Common Stock determined over any 30 consecutive trading days equals or exceeds $12/sh = 45,000; and 20% when the Fair Market Value of a share of Common Stock determined over any 30 consecutive trading days equals or exceeds $16/sh = 22,500.
Documents
Issuer
Sucampo Pharmaceuticals, Inc.
CIK 0001365216
Entity typeother
Related Parties
1- filerCIK 0001383377
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 1:05 PM ET
- Size
- 7.8 KB